New York, New York–(Newsfile Corp. – January 3, 2025) – WHY: The Rosen Law Firm, a global investor rights law firm, is recalling the securities of AstraZeneca PLC (NASDAQ: LON: ) between February 23, 2022 and December 17, 2024, both dates inclusive (the “Class Period”). , of the February 21, 2025 is the plaintiff's deadline in the securities class action filed first by the Firm.
AND THEN: If you purchased AstraZeneca (NASDAQ: ) securities during the Class Offer you may be entitled to a refund without payment of any out-of-pocket costs or expenses for potential financing arrangements.
NEXT TO DO: To join the AstraZeneca class action, go to https://rosenlegal.com/submit-form/?case_id=1331 or call Phillip Kim, Esq. call toll free at 866-767-3653 or email case@rosenlegal.com for information about the class action. A class action lawsuit has already been filed. If you wish to act as a lead plaintiff, you must move the Court no later than February 21, 2025. The lead plaintiff is the party that represents the other class members in managing the lawsuit.
WHY THE LAW CAME OUT: We encourage investors to select qualified advisors with a track record of success in leadership roles. Often times, the firms issuing the notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these companies don't really need security practices, but are middlemen who refer clients or partners to law firms that litigate cases. Be wise in choosing counsel. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class actions and shareholder litigation. The Rosen Law Firm won the largest ever securities settlement for a Chinese company at the time. The Rosen Law Firm was ranked Level 1 by ISS Securities Action (WA:) Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has received hundreds of millions of dollars from investors. In 2019 alone the company secured over $438 million from investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of the Spot Bar. Many of the firm's lawyers are accredited by Lawdragon and Top Lawyers.
CREDIT DETAILS: According to the lawsuit, the defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) AstraZeneca committed insurance fraud in China; (2) as a result, AstraZeneca faced legal exposure in China, which ultimately resulted in AstraZeneca's China President being arrested by Chinese authorities; (3) as a result, AstraZeneca was less exposed to its legal risks; (4) the foregoing, if disclosed, could materially harm AstraZeneca's operations in China; and (5) as a result, the defendants' statements about its business, operations, and prospects, were materially false and misleading and/or unsubstantiated at all relevant times. When true information enters the market, the lawsuit claims that investors suffer damages.
To join the AstraZeneca class action, go to https://rosenlegal.com/submit-form/?case_id=1331 call Phillip Kim, Esq. call toll free at 866-767-3653 or email case@rosenlegal.com for information about the class action.
No Class is guaranteed. Until the class is confirmed, you are not represented by counsel unless you have retained one. You can choose the advice of your choice. You can remain a member of the missing class and do nothing for now. The investor's ability to share in any future recovery is not dependent on serving as the lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:): https:// twitter.com/rosen_firm /www.facebook.com/rosenlawfirm.
Marketing Lawyer. Previous results do not confirm the same result.
——————————
To view the source version of this announcement, please visit https://www.newsfilecorp.com/release/236042